A Nomogram-Based Prognostic Model for Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib: A Multicenter Study

Among scores and staging systems used for HCC, none showed a good prognostic ability in patients with advanced HCC treated with Sorafenib. We aimed to evaluate predictive factors of overall survival (OS) and drug response in HCC patients undergoing Sorafenib included in the Italian Liver Cancer (ITA...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancers 2021-05, Vol.13 (11), p.2677
Hauptverfasser:	Marasco, Giovanni, Poggioli, Francesco, Colecchia, Antonio, Cabibbo, Giuseppe, Pelizzaro, Filippo, Giannini, Edoardo, Marinelli, Sara, Rapaccini, Gian, Caturelli, Eugenio, Di Marco, Mariella, Biasini, Elisabetta, Marra, Fabio, Morisco, Filomena, Foschi, Francesco, Zoli, Marco, Gasbarrini, Antonio, Svegliati Baroni, Gianluca, Masotto, Alberto, Sacco, Rodolfo, Raimondo, Giovanni, Azzaroli, Francesco, Mega, Andrea, Vidili, Gianpaolo, Brunetto, Maurizia, Nardone, Gerardo, Alemanni, Luigina, Dajti, Elton, Ravaioli, Federico, Festi, Davide, Trevisani, Franco
Format:	Artikel
Sprache:	eng
Schlagworte:	Adverse events Bilirubin Cancer therapies Cohort analysis Hemoglobin Hepatitis Hepatocellular carcinoma Laboratories Liver cancer Liver diseases Medical prognosis Multivariate analysis Patients Platelets Statistical analysis Survival Variables α-Fetoprotein
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!